{"id": "article-18645_0", "title": "Acute Bronchitis -- Continuing Education Activity", "content": "Acute bronchitis, characterized by inflammation in the bronchi lining, is a frequent condition in emergency departments, urgent care centers, and primary care offices. Acute bronchitis ranks among the top\u00a010 most common outpatient illnesses in the United States, affecting approximately 5% of adults annually. This\u00a0activity\u00a0discusses the evaluation and management of patients afflicted by acute bronchitis, accentuating the pivotal role played by the interprofessional healthcare team in delivering comprehensive care for these individuals. This activity provides healthcare professionals with the latest insights and evidence-based approaches to enhance their competence in diagnosing and managing acute bronchitis, ultimately improving patient outcomes and healthcare team performance.", "contents": "Acute Bronchitis -- Continuing Education Activity. Acute bronchitis, characterized by inflammation in the bronchi lining, is a frequent condition in emergency departments, urgent care centers, and primary care offices. Acute bronchitis ranks among the top\u00a010 most common outpatient illnesses in the United States, affecting approximately 5% of adults annually. This\u00a0activity\u00a0discusses the evaluation and management of patients afflicted by acute bronchitis, accentuating the pivotal role played by the interprofessional healthcare team in delivering comprehensive care for these individuals. This activity provides healthcare professionals with the latest insights and evidence-based approaches to enhance their competence in diagnosing and managing acute bronchitis, ultimately improving patient outcomes and healthcare team performance."}
{"id": "article-18645_1", "title": "Acute Bronchitis -- Continuing Education Activity", "content": "Objectives: Apply\u00a0the key clinical features of acute bronchitis for an accurate diagnosis\u00a0to distinguish it from other respiratory conditions and differentiate between viral and bacterial causes. Assess\u00a0patients presenting with acute bronchitis for underlying risk factors, such as chronic obstructive pulmonary disease (COPD), asthma, or immunosuppression, to\u00a0develop appropriate\u00a0management plans. Implement evidence-based guidelines and treatment options for acute bronchitis, emphasizing nonpharmacological and pharmacological interventions as needed. Collaborate with the interprofessional team\u00a0to collectively provide evidence-based\u00a0education on acute bronchitis, treatment expectations, and preventive measures. Access free multiple choice questions on this topic.", "contents": "Acute Bronchitis -- Continuing Education Activity. Objectives: Apply\u00a0the key clinical features of acute bronchitis for an accurate diagnosis\u00a0to distinguish it from other respiratory conditions and differentiate between viral and bacterial causes. Assess\u00a0patients presenting with acute bronchitis for underlying risk factors, such as chronic obstructive pulmonary disease (COPD), asthma, or immunosuppression, to\u00a0develop appropriate\u00a0management plans. Implement evidence-based guidelines and treatment options for acute bronchitis, emphasizing nonpharmacological and pharmacological interventions as needed. Collaborate with the interprofessional team\u00a0to collectively provide evidence-based\u00a0education on acute bronchitis, treatment expectations, and preventive measures. Access free multiple choice questions on this topic."}
{"id": "article-18645_2", "title": "Acute Bronchitis -- Introduction", "content": "Acute bronchitis, a prevalent respiratory infection, is a significant medical concern, particularly among adult patients. This condition involves the lower respiratory tract, specifically\u00a0targeting the bronchi, the prominent air passages responsible for air transport within the lungs. Acute bronchitis manifests as an\u00a0inflammation of these bronchi without evidence of pneumonia and typically\u00a0affects\u00a0individuals without underlying chronic obstructive pulmonary disease (COPD).", "contents": "Acute Bronchitis -- Introduction. Acute bronchitis, a prevalent respiratory infection, is a significant medical concern, particularly among adult patients. This condition involves the lower respiratory tract, specifically\u00a0targeting the bronchi, the prominent air passages responsible for air transport within the lungs. Acute bronchitis manifests as an\u00a0inflammation of these bronchi without evidence of pneumonia and typically\u00a0affects\u00a0individuals without underlying chronic obstructive pulmonary disease (COPD)."}
{"id": "article-18645_3", "title": "Acute Bronchitis -- Introduction", "content": "Acute bronchitis is characterized by\u00a0an\u00a0acute onset of a persistent cough, with or without sputum production. As a self-limiting condition, it typically follows a benign course, resolving spontaneously over 1 to 3 weeks. The etiology of these symptoms arises from\u00a0the inflammatory response within\u00a0the lower respiratory tract, often\u00a0triggered by\u00a0viral infections. [1] [2] [3]", "contents": "Acute Bronchitis -- Introduction. Acute bronchitis is characterized by\u00a0an\u00a0acute onset of a persistent cough, with or without sputum production. As a self-limiting condition, it typically follows a benign course, resolving spontaneously over 1 to 3 weeks. The etiology of these symptoms arises from\u00a0the inflammatory response within\u00a0the lower respiratory tract, often\u00a0triggered by\u00a0viral infections. [1] [2] [3]"}
{"id": "article-18645_4", "title": "Acute Bronchitis -- Etiology", "content": "Acute bronchitis presents as a clinical syndrome characterized by a\u00a0transient\u00a0and self-limiting inflammation, specifically\u00a0targeting the larger and mid-sized airways, and devoid of any evidence of pneumonia\u00a0upon\u00a0chest radiography examination.", "contents": "Acute Bronchitis -- Etiology. Acute bronchitis presents as a clinical syndrome characterized by a\u00a0transient\u00a0and self-limiting inflammation, specifically\u00a0targeting the larger and mid-sized airways, and devoid of any evidence of pneumonia\u00a0upon\u00a0chest radiography examination."}
{"id": "article-18645_5", "title": "Acute Bronchitis -- Etiology", "content": "This condition primarily\u00a0impacts\u00a0the bronchial tree,\u00a0leading to irritation, inflammation, and increased mucus production. Viral infections, such as the common cold or influenza viruses, adenovirus, and rhinovirus, are frequent instigators, although exposure to irritants or other respiratory pathogens can also be putative triggers. [4] These viruses\u00a0are transmitted\u00a0through respiratory droplets and\u00a0induce inflammation and irritation within the bronchial tree, ultimately leading to the characteristic symptoms of acute bronchitis,\u00a0which encompass\u00a0coughing, sputum production, and respiratory discomfort.", "contents": "Acute Bronchitis -- Etiology. This condition primarily\u00a0impacts\u00a0the bronchial tree,\u00a0leading to irritation, inflammation, and increased mucus production. Viral infections, such as the common cold or influenza viruses, adenovirus, and rhinovirus, are frequent instigators, although exposure to irritants or other respiratory pathogens can also be putative triggers. [4] These viruses\u00a0are transmitted\u00a0through respiratory droplets and\u00a0induce inflammation and irritation within the bronchial tree, ultimately leading to the characteristic symptoms of acute bronchitis,\u00a0which encompass\u00a0coughing, sputum production, and respiratory discomfort."}
{"id": "article-18645_6", "title": "Acute Bronchitis -- Etiology", "content": "Bacterial pathogens play a role in approximately 10% or less of\u00a0acute bronchitis instances. Among these bacterial pathogens, Mycoplasma pneumoniae , Chlamydia pneumoniae , and Bordetella pertussis are the most commonly identified offenders. [5] In contrast, the majority, approximately 90% to 95%, of cases in healthy adults are attributed to viral infections. Additional\u00a0factors,\u00a0including allergens, irritants, and occasionally bacterial pathogens, can also\u00a0incite\u00a0acute bronchitis. [6]", "contents": "Acute Bronchitis -- Etiology. Bacterial pathogens play a role in approximately 10% or less of\u00a0acute bronchitis instances. Among these bacterial pathogens, Mycoplasma pneumoniae , Chlamydia pneumoniae , and Bordetella pertussis are the most commonly identified offenders. [5] In contrast, the majority, approximately 90% to 95%, of cases in healthy adults are attributed to viral infections. Additional\u00a0factors,\u00a0including allergens, irritants, and occasionally bacterial pathogens, can also\u00a0incite\u00a0acute bronchitis. [6]"}
{"id": "article-18645_7", "title": "Acute Bronchitis -- Etiology", "content": "A higher prevalence of\u00a0influenza viruses A and B are seen in the winter months, escalating transmission and infection rates.\u00a0These viruses\u00a0exhibit ease in spreading within crowded indoor settings like\u00a0schools, workplaces, and public gatherings, where close interpersonal contact facilitates their transmission through respiratory droplets.\u00a0Influenza viruses' efficiency in infecting and replicating within the respiratory tract allows for rapid viral multiplication,\u00a0culminating in\u00a0significant damage to the bronchiolar epithelial cells. This damage,\u00a0coupled with the body's immune response,\u00a0contributes to\u00a0the\u00a0distinctive symptoms of acute bronchitis. [7] [8]", "contents": "Acute Bronchitis -- Etiology. A higher prevalence of\u00a0influenza viruses A and B are seen in the winter months, escalating transmission and infection rates.\u00a0These viruses\u00a0exhibit ease in spreading within crowded indoor settings like\u00a0schools, workplaces, and public gatherings, where close interpersonal contact facilitates their transmission through respiratory droplets.\u00a0Influenza viruses' efficiency in infecting and replicating within the respiratory tract allows for rapid viral multiplication,\u00a0culminating in\u00a0significant damage to the bronchiolar epithelial cells. This damage,\u00a0coupled with the body's immune response,\u00a0contributes to\u00a0the\u00a0distinctive symptoms of acute bronchitis. [7] [8]"}
{"id": "article-18645_8", "title": "Acute Bronchitis -- Etiology", "content": "While\u00a0viral infections are more prevalent\u00a0during the winter season,\u00a0acute bronchitis can arise at any time of the year, often linked to\u00a0strains of adenovirus, rhinovirus, and coronavirus. [9] [10] Furthermore, understanding the dynamics of viral infections causing acute bronchitis throughout the year is essential for healthcare providers and public health officials in implementing effective prevention and control strategies, especially in the context of evolving respiratory viruses and changing environmental factors. Examples of this are as follows:", "contents": "Acute Bronchitis -- Etiology. While\u00a0viral infections are more prevalent\u00a0during the winter season,\u00a0acute bronchitis can arise at any time of the year, often linked to\u00a0strains of adenovirus, rhinovirus, and coronavirus. [9] [10] Furthermore, understanding the dynamics of viral infections causing acute bronchitis throughout the year is essential for healthcare providers and public health officials in implementing effective prevention and control strategies, especially in the context of evolving respiratory viruses and changing environmental factors. Examples of this are as follows:"}
{"id": "article-18645_9", "title": "Acute Bronchitis -- Etiology", "content": "Influenza, RSV, and human coronaviruses typically exhibit peak incidence during winter. As stated previously,\u00a0this seasonal pattern\u00a0arises as people tend to spend more time indoors and\u00a0engage in\u00a0close\u00a0interpersonal contact, creating an environment conducive to the rapid transmission of these viruses. Rhinoviruses\u00a0typically experience peaks in incidence during the spring and fall seasons, coinciding with shifts in weather patterns. Seasonal allergies may also contribute to these peaks by potentially facilitating the transmission of the virus during these times. Enteroviruses, a group encompassing several viruses\u00a0responsible for respiratory and gastrointestinal illnesses, peak in summer. This case surge aligns with increased outdoor activities, providing more significant opportunities for viral transmission.", "contents": "Acute Bronchitis -- Etiology. Influenza, RSV, and human coronaviruses typically exhibit peak incidence during winter. As stated previously,\u00a0this seasonal pattern\u00a0arises as people tend to spend more time indoors and\u00a0engage in\u00a0close\u00a0interpersonal contact, creating an environment conducive to the rapid transmission of these viruses. Rhinoviruses\u00a0typically experience peaks in incidence during the spring and fall seasons, coinciding with shifts in weather patterns. Seasonal allergies may also contribute to these peaks by potentially facilitating the transmission of the virus during these times. Enteroviruses, a group encompassing several viruses\u00a0responsible for respiratory and gastrointestinal illnesses, peak in summer. This case surge aligns with increased outdoor activities, providing more significant opportunities for viral transmission."}
{"id": "article-18645_10", "title": "Acute Bronchitis -- Etiology", "content": "Vaccination status, particularly against viruses like influenza,\u00a0can influence the etiology of acute bronchitis. A study conducted in France revealed that\u00a0among 164 cases of acute bronchitis in adults who have received influenza vaccination,\u00a037% were found to have a viral origin.\u00a0Within the identified\u00a0viral causes, 21% of cases were attributed to rhinovirus. This underscores that despite being vaccinated\u00a0against influenza, individuals\u00a0may remain\u00a0susceptible to rhinovirus infections,\u00a0which can manifest\u00a0as bronchitis symptoms. [11]", "contents": "Acute Bronchitis -- Etiology. Vaccination status, particularly against viruses like influenza,\u00a0can influence the etiology of acute bronchitis. A study conducted in France revealed that\u00a0among 164 cases of acute bronchitis in adults who have received influenza vaccination,\u00a037% were found to have a viral origin.\u00a0Within the identified\u00a0viral causes, 21% of cases were attributed to rhinovirus. This underscores that despite being vaccinated\u00a0against influenza, individuals\u00a0may remain\u00a0susceptible to rhinovirus infections,\u00a0which can manifest\u00a0as bronchitis symptoms. [11]"}
{"id": "article-18645_11", "title": "Acute Bronchitis -- Etiology", "content": "Exposure to irritants\u00a0such as smoke, contaminated\u00a0air, dust, and other environmental pollutants can also cause acute bronchitis or exacerbate preexisting respiratory conditions. Furthermore, allergens can trigger an allergic response\u00a0within the airways, ultimately culminating\u00a0in inflammation and the onset of bronchitis symptoms, particularly in individuals who are susceptible to such triggers. [12]", "contents": "Acute Bronchitis -- Etiology. Exposure to irritants\u00a0such as smoke, contaminated\u00a0air, dust, and other environmental pollutants can also cause acute bronchitis or exacerbate preexisting respiratory conditions. Furthermore, allergens can trigger an allergic response\u00a0within the airways, ultimately culminating\u00a0in inflammation and the onset of bronchitis symptoms, particularly in individuals who are susceptible to such triggers. [12]"}
{"id": "article-18645_12", "title": "Acute Bronchitis -- Epidemiology", "content": "Acute bronchitis represents a common clinical presentation across various\u00a0healthcare settings. In the United States, approximately 5% of individuals annually report physician-diagnosed cases of acute bronchitis. The\u00a0numbers tend to peak during winter, aligning with the seasonal prevalence of respiratory viral infections like influenza and RSV, which often coincide with flu season. [13] [14]", "contents": "Acute Bronchitis -- Epidemiology. Acute bronchitis represents a common clinical presentation across various\u00a0healthcare settings. In the United States, approximately 5% of individuals annually report physician-diagnosed cases of acute bronchitis. The\u00a0numbers tend to peak during winter, aligning with the seasonal prevalence of respiratory viral infections like influenza and RSV, which often coincide with flu season. [13] [14]"}
{"id": "article-18645_13", "title": "Acute Bronchitis -- Epidemiology", "content": "Similarly, a\u00a0study conducted in the United Kingdom reported similar rates of acute bronchitis, with an incidence of 54 cases per 1000 persons. Notably,\u00a0these rates\u00a0exhibit variability\u00a0among different age groups, with lower rates among younger men (36 per 1000) and higher rates in individuals older than 85 (225 per 1000). [8] These discrepancies in incidence may\u00a0be attributed to variations in healthcare-seeking behavior, age-related immune responses, and exposure to viral pathogens in different settings.", "contents": "Acute Bronchitis -- Epidemiology. Similarly, a\u00a0study conducted in the United Kingdom reported similar rates of acute bronchitis, with an incidence of 54 cases per 1000 persons. Notably,\u00a0these rates\u00a0exhibit variability\u00a0among different age groups, with lower rates among younger men (36 per 1000) and higher rates in individuals older than 85 (225 per 1000). [8] These discrepancies in incidence may\u00a0be attributed to variations in healthcare-seeking behavior, age-related immune responses, and exposure to viral pathogens in different settings."}
{"id": "article-18645_14", "title": "Acute Bronchitis -- Epidemiology", "content": "In addition, several risk factors contribute to the development of acute bronchitis, including a history of smoking,\u00a0residence in polluted areas, crowded living conditions, and a prior history of asthma. Specific allergens such as pollen, perfume, and vapors can potentially trigger acute bronchitis in susceptible individuals.", "contents": "Acute Bronchitis -- Epidemiology. In addition, several risk factors contribute to the development of acute bronchitis, including a history of smoking,\u00a0residence in polluted areas, crowded living conditions, and a prior history of asthma. Specific allergens such as pollen, perfume, and vapors can potentially trigger acute bronchitis in susceptible individuals."}
{"id": "article-18645_15", "title": "Acute Bronchitis -- Epidemiology", "content": "In instances where the\u00a0infection is of bacterial origin, the isolated pathogens\u00a0tend to overlap with those commonly associated with\u00a0community-acquired pneumonia.\u00a0Examples of such pathogens are Streptococcus pneumonia and Staphylococcus aureus . [15] [16]", "contents": "Acute Bronchitis -- Epidemiology. In instances where the\u00a0infection is of bacterial origin, the isolated pathogens\u00a0tend to overlap with those commonly associated with\u00a0community-acquired pneumonia.\u00a0Examples of such pathogens are Streptococcus pneumonia and Staphylococcus aureus . [15] [16]"}
{"id": "article-18645_16", "title": "Acute Bronchitis -- Pathophysiology", "content": "Acute bronchitis is inflammation affecting the large and mid-sized airways (bronchi), frequently precipitated by viral infections. The wide\u00a0array of\u00a0anatomical sites within the respiratory tract where these pathogens can take hold underscores the diverse impact of these microorganisms on the respiratory tract. A study involving volunteers exposed to rhinovirus infections demonstrated the\u00a0various\u00a0locations within the respiratory system where the virus could be detected. [9]", "contents": "Acute Bronchitis -- Pathophysiology. Acute bronchitis is inflammation affecting the large and mid-sized airways (bronchi), frequently precipitated by viral infections. The wide\u00a0array of\u00a0anatomical sites within the respiratory tract where these pathogens can take hold underscores the diverse impact of these microorganisms on the respiratory tract. A study involving volunteers exposed to rhinovirus infections demonstrated the\u00a0various\u00a0locations within the respiratory system where the virus could be detected. [9]"}
{"id": "article-18645_17", "title": "Acute Bronchitis -- Pathophysiology", "content": "The inflammatory process\u00a0triggers\u00a0increased blood flow and cellular activity\u00a0within the affected bronchi,\u00a0resulting in\u00a0heightened\u00a018F-fluorodeoxyglucose (FDG) uptake when observed via positron-emission tomography (PET) scan. [17] Additionally, bronchial inflammation can stem from various triggers, with viral infections, allergens, and pollutants among the most common culprits. The inflammation of the bronchial wall leads to mucosal thickening, epithelial cell desquamation, and denudation of the basement membrane. In some instances, a viral upper respiratory infection can progress to a lower respiratory tract infection, resulting in acute bronchitis. [18]", "contents": "Acute Bronchitis -- Pathophysiology. The inflammatory process\u00a0triggers\u00a0increased blood flow and cellular activity\u00a0within the affected bronchi,\u00a0resulting in\u00a0heightened\u00a018F-fluorodeoxyglucose (FDG) uptake when observed via positron-emission tomography (PET) scan. [17] Additionally, bronchial inflammation can stem from various triggers, with viral infections, allergens, and pollutants among the most common culprits. The inflammation of the bronchial wall leads to mucosal thickening, epithelial cell desquamation, and denudation of the basement membrane. In some instances, a viral upper respiratory infection can progress to a lower respiratory tract infection, resulting in acute bronchitis. [18]"}
{"id": "article-18645_18", "title": "Acute Bronchitis -- History and Physical", "content": "Patients\u00a0affected with acute bronchitis typically exhibit a range of symptoms, including a productive cough, feelings of malaise, breathing difficulties, and wheezing. Often, the most prominent complaint is the persistent cough, with an accompanying clear or yellowish sputum production. However,\u00a0on occasion, the sputum can take on a\u00a0purulent appearance. Purulent sputum does not necessarily correlate with a bacterial infection or necessitate antibiotic treatment. [19]", "contents": "Acute Bronchitis -- History and Physical. Patients\u00a0affected with acute bronchitis typically exhibit a range of symptoms, including a productive cough, feelings of malaise, breathing difficulties, and wheezing. Often, the most prominent complaint is the persistent cough, with an accompanying clear or yellowish sputum production. However,\u00a0on occasion, the sputum can take on a\u00a0purulent appearance. Purulent sputum does not necessarily correlate with a bacterial infection or necessitate antibiotic treatment. [19]"}
{"id": "article-18645_19", "title": "Acute Bronchitis -- History and Physical", "content": "Following an episode of acute bronchitis, the cough typically persists for 10 to 20 days, with a median duration of 18 days. [20] Occasionally, bronchitis cough may extend beyond 4 weeks. Paroxysms of cough accompanied by an inspiratory whoop or posttussive emesis should raise concerns for pertussis infection.", "contents": "Acute Bronchitis -- History and Physical. Following an episode of acute bronchitis, the cough typically persists for 10 to 20 days, with a median duration of 18 days. [20] Occasionally, bronchitis cough may extend beyond 4 weeks. Paroxysms of cough accompanied by an inspiratory whoop or posttussive emesis should raise concerns for pertussis infection."}
{"id": "article-18645_20", "title": "Acute Bronchitis -- History and Physical", "content": "In\u00a0the\u00a0early stages of infection, the symptoms of mild upper respiratory infections and acute bronchitis can often overlap, creating a\u00a0challenge\u00a0in distinguishing between both based solely on symptoms. Both conditions may present with common respiratory symptoms such as:", "contents": "Acute Bronchitis -- History and Physical. In\u00a0the\u00a0early stages of infection, the symptoms of mild upper respiratory infections and acute bronchitis can often overlap, creating a\u00a0challenge\u00a0in distinguishing between both based solely on symptoms. Both conditions may present with common respiratory symptoms such as:"}
{"id": "article-18645_21", "title": "Acute Bronchitis -- History and Physical", "content": "Cough: Initially, the cough may start as dry and irritating, but as acute bronchitis advances, it can transition to\u00a0producing\u00a0sputum. In acute bronchitis, this cough tends to persist for longer, often extending beyond 5 days. Approximately 50% of patients with acute bronchitis report the production of purulent sputum. [21] Prolonged\u00a0or forceful coughing may lead to chest wall or substernal musculoskeletal pain, usually self-limiting. Mild fever: A low-grade fever may be present in both conditions,\u00a0although it is more frequently associated with upper respiratory infections. The presence of high-grade fevers in the setting of acute bronchitis is unusual and warrants further diagnostic evaluation. Fatigue and body aches: Mild upper respiratory infections and acute bronchitis can cause fatigue and general bodily discomfort.", "contents": "Acute Bronchitis -- History and Physical. Cough: Initially, the cough may start as dry and irritating, but as acute bronchitis advances, it can transition to\u00a0producing\u00a0sputum. In acute bronchitis, this cough tends to persist for longer, often extending beyond 5 days. Approximately 50% of patients with acute bronchitis report the production of purulent sputum. [21] Prolonged\u00a0or forceful coughing may lead to chest wall or substernal musculoskeletal pain, usually self-limiting. Mild fever: A low-grade fever may be present in both conditions,\u00a0although it is more frequently associated with upper respiratory infections. The presence of high-grade fevers in the setting of acute bronchitis is unusual and warrants further diagnostic evaluation. Fatigue and body aches: Mild upper respiratory infections and acute bronchitis can cause fatigue and general bodily discomfort."}
{"id": "article-18645_22", "title": "Acute Bronchitis -- History and Physical", "content": "The\u00a0differentiation between these\u00a02 conditions becomes\u00a0more apparent as the infection develops. If the symptoms predominantly\u00a0affect the upper respiratory tract and resolve within a few days, it is more likely to be a mild upper respiratory infection. Conversely, if the symptoms persist for a week or\u00a0longer and are accompanied by lower respiratory tract symptoms, this presentation indicates\u00a0acute bronchitis.", "contents": "Acute Bronchitis -- History and Physical. The\u00a0differentiation between these\u00a02 conditions becomes\u00a0more apparent as the infection develops. If the symptoms predominantly\u00a0affect the upper respiratory tract and resolve within a few days, it is more likely to be a mild upper respiratory infection. Conversely, if the symptoms persist for a week or\u00a0longer and are accompanied by lower respiratory tract symptoms, this presentation indicates\u00a0acute bronchitis."}
{"id": "article-18645_23", "title": "Acute Bronchitis -- History and Physical", "content": "During a\u00a0physical examination, lung auscultation may reveal\u00a0the presence of\u00a0wheezing. In some instances, the\u00a0detection\u00a0of rhonchi may improve or clear with coughing,\u00a0suggesting that the airway secretions or obstruction causing the sound can be\u00a0alleviated\u00a0through coughing efforts.", "contents": "Acute Bronchitis -- History and Physical. During a\u00a0physical examination, lung auscultation may reveal\u00a0the presence of\u00a0wheezing. In some instances, the\u00a0detection\u00a0of rhonchi may improve or clear with coughing,\u00a0suggesting that the airway secretions or obstruction causing the sound can be\u00a0alleviated\u00a0through coughing efforts."}
{"id": "article-18645_24", "title": "Acute Bronchitis -- History and Physical", "content": "Pneumonia should be considered a potential diagnosis when detecting rales or egophony. Mild tachycardia may accompany these findings, indicating fever and dehydration secondary to the viral illness. It is important to note that similar signs of tachycardia can also be observed in bacterial infections. In general, the evaluation of the rest of the body systems typically falls within normal limits.", "contents": "Acute Bronchitis -- History and Physical. Pneumonia should be considered a potential diagnosis when detecting rales or egophony. Mild tachycardia may accompany these findings, indicating fever and dehydration secondary to the viral illness. It is important to note that similar signs of tachycardia can also be observed in bacterial infections. In general, the evaluation of the rest of the body systems typically falls within normal limits."}
{"id": "article-18645_25", "title": "Acute Bronchitis -- Evaluation", "content": "Acute bronchitis is typically\u00a0diagnosed clinically, relying\u00a0on a comprehensive assessment encompassing a medical history,\u00a0pulmonary examination, and other pertinent physical findings. The evaluation of oxygen saturation, along with the assessment of pulse rate, temperature, and respiratory rate, serves as a pivotal indicator for gauging the severity of the condition. In cases where vital signs fall within normal ranges and no physical examination findings suggest pneumonia, further diagnostic investigations are generally unnecessary. However, an exception to this rule applies to\u00a0older patients (>75 years) or\u00a0individuals with neurocognitive impairment. In such instances,\u00a0a more extensive workup should be considered part of the evaluation process.", "contents": "Acute Bronchitis -- Evaluation. Acute bronchitis is typically\u00a0diagnosed clinically, relying\u00a0on a comprehensive assessment encompassing a medical history,\u00a0pulmonary examination, and other pertinent physical findings. The evaluation of oxygen saturation, along with the assessment of pulse rate, temperature, and respiratory rate, serves as a pivotal indicator for gauging the severity of the condition. In cases where vital signs fall within normal ranges and no physical examination findings suggest pneumonia, further diagnostic investigations are generally unnecessary. However, an exception to this rule applies to\u00a0older patients (>75 years) or\u00a0individuals with neurocognitive impairment. In such instances,\u00a0a more extensive workup should be considered part of the evaluation process."}
{"id": "article-18645_26", "title": "Acute Bronchitis -- Evaluation", "content": "Chest x-ray (CXR) findings in cases of acute bronchitis are\u00a0generally\u00a0nonspecific and\u00a0often appear\u00a0normal. The\u00a0CXR\u00a0findings may occasionally reveal increased interstitial markings indicative of bronchial wall thickening. A\u00a0CXR proves particularly valuable in distinguishing pneumonia from acute bronchitis when infiltrates are present. Evidence-based guidelines established by the American College of Chest Physicians (ACCP) recommend obtaining a CXR where specific criteria are met, including the following: [14] Heart rate exceeding 100 bpm Respiratory rate greater than 24 breaths/min Oral body temperature surpassing 38 \u00b0C Chest examination findings of egophony or fremitus", "contents": "Acute Bronchitis -- Evaluation. Chest x-ray (CXR) findings in cases of acute bronchitis are\u00a0generally\u00a0nonspecific and\u00a0often appear\u00a0normal. The\u00a0CXR\u00a0findings may occasionally reveal increased interstitial markings indicative of bronchial wall thickening. A\u00a0CXR proves particularly valuable in distinguishing pneumonia from acute bronchitis when infiltrates are present. Evidence-based guidelines established by the American College of Chest Physicians (ACCP) recommend obtaining a CXR where specific criteria are met, including the following: [14] Heart rate exceeding 100 bpm Respiratory rate greater than 24 breaths/min Oral body temperature surpassing 38 \u00b0C Chest examination findings of egophony or fremitus"}
{"id": "article-18645_27", "title": "Acute Bronchitis -- Evaluation", "content": "Laboratory testing, including a complete blood count and chemistry panel, may be conducted as part of the diagnostic\u00a0workup for fever. The white blood count might\u00a0show a mild\u00a0elevation\u00a0in some cases of acute bronchitis.", "contents": "Acute Bronchitis -- Evaluation. Laboratory testing, including a complete blood count and chemistry panel, may be conducted as part of the diagnostic\u00a0workup for fever. The white blood count might\u00a0show a mild\u00a0elevation\u00a0in some cases of acute bronchitis."}
{"id": "article-18645_28", "title": "Acute Bronchitis -- Evaluation", "content": "Rapid microbiological testing for respiratory infections may not always be cost-effective or\u00a0essential in every situation. Nevertheless, specific scenarios exist in which testing can be beneficial and\u00a0potentially result\u00a0in alterations to the treatment approach. Some of these circumstances include:", "contents": "Acute Bronchitis -- Evaluation. Rapid microbiological testing for respiratory infections may not always be cost-effective or\u00a0essential in every situation. Nevertheless, specific scenarios exist in which testing can be beneficial and\u00a0potentially result\u00a0in alterations to the treatment approach. Some of these circumstances include:"}
{"id": "article-18645_29", "title": "Acute Bronchitis -- Evaluation", "content": "Influenza season: During the influenza season, rapid testing for influenza may be recommended in specific patient populations. This population includes individuals at a\u00a0heightened risk\u00a0of\u00a0complications, such as older individuals, young children, pregnant women, and\u00a0individuals with chronic medical conditions. Healthcare workers who develop respiratory symptoms may also benefit from rapid testing to determine the presence\u00a0of influenza and assess the appropriateness of the antiviral treatment.", "contents": "Acute Bronchitis -- Evaluation. Influenza season: During the influenza season, rapid testing for influenza may be recommended in specific patient populations. This population includes individuals at a\u00a0heightened risk\u00a0of\u00a0complications, such as older individuals, young children, pregnant women, and\u00a0individuals with chronic medical conditions. Healthcare workers who develop respiratory symptoms may also benefit from rapid testing to determine the presence\u00a0of influenza and assess the appropriateness of the antiviral treatment."}
{"id": "article-18645_30", "title": "Acute Bronchitis -- Evaluation", "content": "Viral pandemics:\u00a0In the context of\u00a0viral pandemics, such as the COVID-19 pandemic, rapid testing becomes essential for diagnosing and managing the infection.\u00a0Swift identification of\u00a0cases is imperative for promptly implementing appropriate infection control measures, timely administration of treatment, and prevention of further\u00a0viral transmission.", "contents": "Acute Bronchitis -- Evaluation. Viral pandemics:\u00a0In the context of\u00a0viral pandemics, such as the COVID-19 pandemic, rapid testing becomes essential for diagnosing and managing the infection.\u00a0Swift identification of\u00a0cases is imperative for promptly implementing appropriate infection control measures, timely administration of treatment, and prevention of further\u00a0viral transmission."}
{"id": "article-18645_31", "title": "Acute Bronchitis -- Evaluation", "content": "High suspicion of pertussis or bacterial infections:\u00a0When a strong clinical suspicion\u00a0of pertussis (whooping cough) or other bacterial respiratory infections arises, rapid testing\u00a0proves valuable in confirming the diagnosis. Such testing can serve as a guide for initiating antibiotic treatment, thereby aiding in the containment of further transmission.", "contents": "Acute Bronchitis -- Evaluation. High suspicion of pertussis or bacterial infections:\u00a0When a strong clinical suspicion\u00a0of pertussis (whooping cough) or other bacterial respiratory infections arises, rapid testing\u00a0proves valuable in confirming the diagnosis. Such testing can serve as a guide for initiating antibiotic treatment, thereby aiding in the containment of further transmission."}
{"id": "article-18645_32", "title": "Acute Bronchitis -- Evaluation", "content": "Multiplex polymerase-chain-reaction (PCR) testing of nasopharyngeal swabs or aspirates is a diagnostic tool that allows for the simultaneous detection of multiple pathogens in a single test. This method helps diagnose infections\u00a0attributed\u00a0to specific bacteria, such as B pertussis (the causative agent of whooping cough), M pneumoniae , or C pneumonia . [22]", "contents": "Acute Bronchitis -- Evaluation. Multiplex polymerase-chain-reaction (PCR) testing of nasopharyngeal swabs or aspirates is a diagnostic tool that allows for the simultaneous detection of multiple pathogens in a single test. This method helps diagnose infections\u00a0attributed\u00a0to specific bacteria, such as B pertussis (the causative agent of whooping cough), M pneumoniae , or C pneumonia . [22]"}
{"id": "article-18645_33", "title": "Acute Bronchitis -- Evaluation", "content": "The advantage of multiplex PCR testing\u00a0lies in its ability to\u00a0rapidly and accurately identify the presence of these bacterial pathogens in respiratory samples, facilitating the differentiation of various causes of respiratory infections.\u00a0By detecting the target bacteria's genetic material (DNA or RNA), PCR testing provides a sensitive and specific diagnosis, especially when compared to traditional culture methods, which may have sensitivity and turnaround time limitations.\u00a0However, it remains essential to ensure this testing approach is adequately validated and employed within a comprehensive clinical assessment context. This approach provides an accurate interpretation of results and supports sound decision-making regarding patient management.\u00a0Gram stain and bacterial sputum cultures are\u00a0typically discouraged in acute bronchitis cases, as bacteria seldom serve as the causative agent.", "contents": "Acute Bronchitis -- Evaluation. The advantage of multiplex PCR testing\u00a0lies in its ability to\u00a0rapidly and accurately identify the presence of these bacterial pathogens in respiratory samples, facilitating the differentiation of various causes of respiratory infections.\u00a0By detecting the target bacteria's genetic material (DNA or RNA), PCR testing provides a sensitive and specific diagnosis, especially when compared to traditional culture methods, which may have sensitivity and turnaround time limitations.\u00a0However, it remains essential to ensure this testing approach is adequately validated and employed within a comprehensive clinical assessment context. This approach provides an accurate interpretation of results and supports sound decision-making regarding patient management.\u00a0Gram stain and bacterial sputum cultures are\u00a0typically discouraged in acute bronchitis cases, as bacteria seldom serve as the causative agent."}
{"id": "article-18645_34", "title": "Acute Bronchitis -- Evaluation", "content": "Assessing\u00a0procalcitonin levels\u00a0can be a valuable tool in\u00a0determining whether antibiotics should be prescribed when the diagnosis of acute bronchitis is uncertain. A meta-analysis has shown that procalcitonin-guided antibiotic therapy reduced antibiotic exposure and improved overall survival. [23]", "contents": "Acute Bronchitis -- Evaluation. Assessing\u00a0procalcitonin levels\u00a0can be a valuable tool in\u00a0determining whether antibiotics should be prescribed when the diagnosis of acute bronchitis is uncertain. A meta-analysis has shown that procalcitonin-guided antibiotic therapy reduced antibiotic exposure and improved overall survival. [23]"}
{"id": "article-18645_35", "title": "Acute Bronchitis -- Evaluation", "content": "Spirometry, when performed,\u00a0reveals transient bronchial hyperresponsiveness in approximately 40% of patients with diagnosed acute bronchitis. A reported 17% of these patients exhibit reversibility of FEV1 (forced expiratory volume in 1 second) greater than 15%. [14] Airflow obstruction and bronchial hyperresponsiveness typically resolve within\u00a06 weeks. [24]", "contents": "Acute Bronchitis -- Evaluation. Spirometry, when performed,\u00a0reveals transient bronchial hyperresponsiveness in approximately 40% of patients with diagnosed acute bronchitis. A reported 17% of these patients exhibit reversibility of FEV1 (forced expiratory volume in 1 second) greater than 15%. [14] Airflow obstruction and bronchial hyperresponsiveness typically resolve within\u00a06 weeks. [24]"}
{"id": "article-18645_36", "title": "Acute Bronchitis -- Treatment / Management", "content": "Acute bronchitis is typically a self-limiting\u00a0condition, and its\u00a0treatment primarily revolves around providing symptomatic and supportive therapy. For alleviating cough, both nonpharmacological and pharmacological approaches\u00a0can be considered. Nonpharmacological strategies include remedies\u00a0such as hot tea, honey, ginger, and throat lozenges. Notably, the efficacy of these interventions has not been evaluated through clinical trials.", "contents": "Acute Bronchitis -- Treatment / Management. Acute bronchitis is typically a self-limiting\u00a0condition, and its\u00a0treatment primarily revolves around providing symptomatic and supportive therapy. For alleviating cough, both nonpharmacological and pharmacological approaches\u00a0can be considered. Nonpharmacological strategies include remedies\u00a0such as hot tea, honey, ginger, and throat lozenges. Notably, the efficacy of these interventions has not been evaluated through clinical trials."}
{"id": "article-18645_37", "title": "Acute Bronchitis -- Treatment / Management", "content": "In clinical practice, antitussive agents like dextromethorphan (with or without codeine) are\u00a0often used to suppress cough based on their effectiveness in managing chronic bronchitis symptoms and data from studies on cough associated with the common cold. No randomized trials specifically assess\u00a0the efficacy in antitussive agents in acute bronchitis. Codeine usage should be avoided due to its addictive potential.", "contents": "Acute Bronchitis -- Treatment / Management. In clinical practice, antitussive agents like dextromethorphan (with or without codeine) are\u00a0often used to suppress cough based on their effectiveness in managing chronic bronchitis symptoms and data from studies on cough associated with the common cold. No randomized trials specifically assess\u00a0the efficacy in antitussive agents in acute bronchitis. Codeine usage should be avoided due to its addictive potential."}
{"id": "article-18645_38", "title": "Acute Bronchitis -- Treatment / Management", "content": "The available data regarding the use of mucolytic agents in acute bronchitis treatment\u00a0are conflicting and lack a clear consensus on efficacy.\u00a0Therefore, these agents' role in managing acute bronchitis remains a subject of ongoing investigation and debate.", "contents": "Acute Bronchitis -- Treatment / Management. The available data regarding the use of mucolytic agents in acute bronchitis treatment\u00a0are conflicting and lack a clear consensus on efficacy.\u00a0Therefore, these agents' role in managing acute bronchitis remains a subject of ongoing investigation and debate."}
{"id": "article-18645_39", "title": "Acute Bronchitis -- Treatment / Management", "content": "Beta-agonists are\u00a0commonly administered to patients with\u00a0acute bronchitis\u00a0who exhibit wheezing.\u00a0However, the findings from small randomized control trials\u00a0investigating the use of beta-agonists for cough in acute bronchitis have yielded mixed results. In a Cochrane review encompassing 5 trials, no substantial benefit of beta-agonists on daily cough was observed, except for a\u00a0minor\u00a0advantage in a subgroup of patients with wheezing and airflow obstruction at baseline. [25] A more recent Cochrane review\u00a0reported similar outcomes. [26]", "contents": "Acute Bronchitis -- Treatment / Management. Beta-agonists are\u00a0commonly administered to patients with\u00a0acute bronchitis\u00a0who exhibit wheezing.\u00a0However, the findings from small randomized control trials\u00a0investigating the use of beta-agonists for cough in acute bronchitis have yielded mixed results. In a Cochrane review encompassing 5 trials, no substantial benefit of beta-agonists on daily cough was observed, except for a\u00a0minor\u00a0advantage in a subgroup of patients with wheezing and airflow obstruction at baseline. [25] A more recent Cochrane review\u00a0reported similar outcomes. [26]"}
{"id": "article-18645_40", "title": "Acute Bronchitis -- Treatment / Management", "content": "Analgesic and antipyretic agents may manage associated symptoms like malaise, myalgia, and fever. Additionally, prednisone or other steroids may be administered to\u00a0address inflammation.\u00a0While the evidence supporting their benefit in acute bronchitis is limited, they can be useful in patients with\u00a0underlying chronic obstructive pulmonary disease (COPD) or asthma. Typically, steroids are utilized as a short-term burst therapy.\u00a0In certain cases,\u00a0an extended tapering\u00a0course of steroids\u00a0may be warranted, especially for patients with underlying asthma or COPD. [27] [28]", "contents": "Acute Bronchitis -- Treatment / Management. Analgesic and antipyretic agents may manage associated symptoms like malaise, myalgia, and fever. Additionally, prednisone or other steroids may be administered to\u00a0address inflammation.\u00a0While the evidence supporting their benefit in acute bronchitis is limited, they can be useful in patients with\u00a0underlying chronic obstructive pulmonary disease (COPD) or asthma. Typically, steroids are utilized as a short-term burst therapy.\u00a0In certain cases,\u00a0an extended tapering\u00a0course of steroids\u00a0may be warranted, especially for patients with underlying asthma or COPD. [27] [28]"}
{"id": "article-18645_41", "title": "Acute Bronchitis -- Treatment / Management", "content": "ACCP guidelines recommend against antibiotic use in cases of\u00a0uncomplicated acute bronchitis\u00a0among otherwise healthy adults. A comprehensive Cochrane review of\u00a09 randomized, controlled trials of antibiotic agents\u00a0found only\u00a0a minor reduction in the total duration of cough (0.6 days) with no significant decrease in the overall duration of illness. [29]", "contents": "Acute Bronchitis -- Treatment / Management. ACCP guidelines recommend against antibiotic use in cases of\u00a0uncomplicated acute bronchitis\u00a0among otherwise healthy adults. A comprehensive Cochrane review of\u00a09 randomized, controlled trials of antibiotic agents\u00a0found only\u00a0a minor reduction in the total duration of cough (0.6 days) with no significant decrease in the overall duration of illness. [29]"}
{"id": "article-18645_42", "title": "Acute Bronchitis -- Treatment / Management", "content": "Consequently,\u00a0antibiotic use should be avoided in\u00a0uncomplicated cases of acute bronchitis, considering factors such as the cost of antibiotics, the\u00a0increasing global concern of antibiotic resistance, and the\u00a0potential\u00a0side effects\u00a0associated with antibiotic usage. Numerous\u00a0other international medical societies\u00a0also advise\u00a0against antibiotic use in cases of viral acute bronchitis. Despite these recommendations, many patients diagnosed with acute bronchitis are prescribed antibiotics.", "contents": "Acute Bronchitis -- Treatment / Management. Consequently,\u00a0antibiotic use should be avoided in\u00a0uncomplicated cases of acute bronchitis, considering factors such as the cost of antibiotics, the\u00a0increasing global concern of antibiotic resistance, and the\u00a0potential\u00a0side effects\u00a0associated with antibiotic usage. Numerous\u00a0other international medical societies\u00a0also advise\u00a0against antibiotic use in cases of viral acute bronchitis. Despite these recommendations, many patients diagnosed with acute bronchitis are prescribed antibiotics."}
{"id": "article-18645_43", "title": "Acute Bronchitis -- Treatment / Management", "content": "It is important to emphasize that no empirical data justify the belief that antibiotic therapy leads to less severe or shorter duration of cough in acute bronchitis. Antimicrobial therapy is recommended only when a treatable pathogen is identified, as with pertussis (see Table. Pathogens and Treatments Related to Acute Bronchitis). Antiviral treatment should be considered for influenza infection.", "contents": "Acute Bronchitis -- Treatment / Management. It is important to emphasize that no empirical data justify the belief that antibiotic therapy leads to less severe or shorter duration of cough in acute bronchitis. Antimicrobial therapy is recommended only when a treatable pathogen is identified, as with pertussis (see Table. Pathogens and Treatments Related to Acute Bronchitis). Antiviral treatment should be considered for influenza infection."}
{"id": "article-18645_44", "title": "Acute Bronchitis -- Treatment / Management", "content": "* The use of oseltamivir and zanamivir has been shown to offer minor benefits in reducing the duration of influenza symptoms by an average of half a day in adults. These medications are also effective in reducing the risk of symptomatic influenza when used as a prophylactic measure. However, limited evidence supports the claim that these drugs can reduce the risk of hospital admission or pneumonia. Furthermore, a Cochrane review suggests that there is insufficient evidence to support the use of neuraminidase inhibitors in preventing the person-to-person spread of influenza. The complications associated with influenza, such as pneumonia, cannot be reduced by treatment trials due to the lack of clear diagnostic definitions. The use of oseltamivir has been found to increase the risk of adverse effects such as nausea, vomiting, psychiatric effects, and renal events in adults. Therefore, the balance between the benefits and harms of using neuraminidase inhibitors for prophylaxis or treatment should be carefully considered when making decisions. [40]", "contents": "Acute Bronchitis -- Treatment / Management. * The use of oseltamivir and zanamivir has been shown to offer minor benefits in reducing the duration of influenza symptoms by an average of half a day in adults. These medications are also effective in reducing the risk of symptomatic influenza when used as a prophylactic measure. However, limited evidence supports the claim that these drugs can reduce the risk of hospital admission or pneumonia. Furthermore, a Cochrane review suggests that there is insufficient evidence to support the use of neuraminidase inhibitors in preventing the person-to-person spread of influenza. The complications associated with influenza, such as pneumonia, cannot be reduced by treatment trials due to the lack of clear diagnostic definitions. The use of oseltamivir has been found to increase the risk of adverse effects such as nausea, vomiting, psychiatric effects, and renal events in adults. Therefore, the balance between the benefits and harms of using neuraminidase inhibitors for prophylaxis or treatment should be carefully considered when making decisions. [40]"}
{"id": "article-18645_45", "title": "Acute Bronchitis -- Treatment / Management", "content": "In summary, robust data are lacking supporting the use of beta-agonists, steroids, neuraminidase inhibitors, and mucolytic agents, particularly in patients without underlying COPD and asthma. Treatment decisions should be based on the individual's response to these interventions and the reported benefits while carefully considering the balance between potential risks and benefits in each case.", "contents": "Acute Bronchitis -- Treatment / Management. In summary, robust data are lacking supporting the use of beta-agonists, steroids, neuraminidase inhibitors, and mucolytic agents, particularly in patients without underlying COPD and asthma. Treatment decisions should be based on the individual's response to these interventions and the reported benefits while carefully considering the balance between potential risks and benefits in each case."}
{"id": "article-18645_46", "title": "Acute Bronchitis -- Differential Diagnosis", "content": "Other potential causes of acute cough should be considered, especially when the cough persists for\u00a0a duration exceeding\u00a03 weeks. Other conditions to consider are as follows: Asthma: Acute asthma exacerbation can be frequently\u00a0misdiagnosed as acute bronchitis, with around one-third of patients presenting with acute cough. Acute or chronic sinusitis Bronchiolitis COPD Gastroesophageal reflux disease (GERD) Viral pharyngitis Heart failure Pulmonary embolism Pneumonia", "contents": "Acute Bronchitis -- Differential Diagnosis. Other potential causes of acute cough should be considered, especially when the cough persists for\u00a0a duration exceeding\u00a03 weeks. Other conditions to consider are as follows: Asthma: Acute asthma exacerbation can be frequently\u00a0misdiagnosed as acute bronchitis, with around one-third of patients presenting with acute cough. Acute or chronic sinusitis Bronchiolitis COPD Gastroesophageal reflux disease (GERD) Viral pharyngitis Heart failure Pulmonary embolism Pneumonia"}
{"id": "article-18645_47", "title": "Acute Bronchitis -- Prognosis", "content": "Acute bronchitis typically follows a self-limiting course and\u00a0frequently improves\u00a0with symptomatic interventions. However, clinicians should remain aware of\u00a0potential secondary complications,\u00a0such as pneumonia. Cases of acute respiratory distress syndrome and respiratory failure associated with acute bronchitis have been documented in the literature. Consequently, while acute bronchitis is often manageable with symptomatic care, the healthcare team should be\u00a0mindful of\u00a0potential complications and\u00a0ready to\u00a0administer appropriate interventions if necessary. [41] [42]", "contents": "Acute Bronchitis -- Prognosis. Acute bronchitis typically follows a self-limiting course and\u00a0frequently improves\u00a0with symptomatic interventions. However, clinicians should remain aware of\u00a0potential secondary complications,\u00a0such as pneumonia. Cases of acute respiratory distress syndrome and respiratory failure associated with acute bronchitis have been documented in the literature. Consequently, while acute bronchitis is often manageable with symptomatic care, the healthcare team should be\u00a0mindful of\u00a0potential complications and\u00a0ready to\u00a0administer appropriate interventions if necessary. [41] [42]"}
{"id": "article-18645_48", "title": "Acute Bronchitis -- Complications", "content": "Complications\u00a0associated with acute bronchitis include: Secondary pneumonia Acute respiratory distress syndrome Prolonged symptoms Spontaneous pneumothorax Spontaneous pneumomediastinum", "contents": "Acute Bronchitis -- Complications. Complications\u00a0associated with acute bronchitis include: Secondary pneumonia Acute respiratory distress syndrome Prolonged symptoms Spontaneous pneumothorax Spontaneous pneumomediastinum"}
{"id": "article-18645_49", "title": "Acute Bronchitis -- Deterrence and Patient Education", "content": "Lifestyle modifications like smoking cessation and\u00a0minimizing exposure to allergens and pollutants are essential in\u00a0preventing the recurrence of acute bronchitis and reducing the risk of complications. The flu and pneumonia vaccines are particularly advised\u00a0in\u00a0specific groups, including adults\u00a065 and older, children younger than 2 years (but older than\u00a06 months), pregnant women, and\u00a0individuals residing in\u00a0nursing homes and long-term care facilities. People with conditions like asthma, COPD, and other individuals who are immunocompromised also risk\u00a0developing complications. Recurrence occurs in up to one-third of acute bronchitis cases.", "contents": "Acute Bronchitis -- Deterrence and Patient Education. Lifestyle modifications like smoking cessation and\u00a0minimizing exposure to allergens and pollutants are essential in\u00a0preventing the recurrence of acute bronchitis and reducing the risk of complications. The flu and pneumonia vaccines are particularly advised\u00a0in\u00a0specific groups, including adults\u00a065 and older, children younger than 2 years (but older than\u00a06 months), pregnant women, and\u00a0individuals residing in\u00a0nursing homes and long-term care facilities. People with conditions like asthma, COPD, and other individuals who are immunocompromised also risk\u00a0developing complications. Recurrence occurs in up to one-third of acute bronchitis cases."}
{"id": "article-18645_50", "title": "Acute Bronchitis -- Deterrence and Patient Education", "content": "Additionally, patients should receive education regarding the risks\u00a0associated with unnecessary antibiotic prescriptions, including the development of antibiotic resistance, cost implications, and potential\u00a0adverse\u00a0effects. Patients should be encouraged to engage in open and informed discussions with their healthcare\u00a0practitioners to ensure that treatment decisions align with their clinical needs, promoting effective and responsible healthcare practices.", "contents": "Acute Bronchitis -- Deterrence and Patient Education. Additionally, patients should receive education regarding the risks\u00a0associated with unnecessary antibiotic prescriptions, including the development of antibiotic resistance, cost implications, and potential\u00a0adverse\u00a0effects. Patients should be encouraged to engage in open and informed discussions with their healthcare\u00a0practitioners to ensure that treatment decisions align with their clinical needs, promoting effective and responsible healthcare practices."}
{"id": "article-18645_51", "title": "Acute Bronchitis -- Pearls and Other Issues", "content": "Acute bronchitis is a very common respiratory symptom that affects the bronchial tree. The majority (90%) of cases are caused by viruses, resulting in inflammation and increased mucus production. Occasionally, secondary pneumonia can develop, typically characterized\u00a0by worsening symptoms, a productive cough, and fever. In such cases, a\u00a0CXR is advisable, particularly for adults in an immunocompromised state, older individuals,\u00a0infants, newborns, and individuals who smoke.", "contents": "Acute Bronchitis -- Pearls and Other Issues. Acute bronchitis is a very common respiratory symptom that affects the bronchial tree. The majority (90%) of cases are caused by viruses, resulting in inflammation and increased mucus production. Occasionally, secondary pneumonia can develop, typically characterized\u00a0by worsening symptoms, a productive cough, and fever. In such cases, a\u00a0CXR is advisable, particularly for adults in an immunocompromised state, older individuals,\u00a0infants, newborns, and individuals who smoke."}
{"id": "article-18645_52", "title": "Acute Bronchitis -- Pearls and Other Issues", "content": "Identifying the pathogen responsible for acute bronchitis is helpful, although not always necessary. In recent years, new technological developments have made this possible, such as multiplex polymerase-chain reaction (PCR) testing of nasopharyngeal swabs that can identify more than one organism at once.", "contents": "Acute Bronchitis -- Pearls and Other Issues. Identifying the pathogen responsible for acute bronchitis is helpful, although not always necessary. In recent years, new technological developments have made this possible, such as multiplex polymerase-chain reaction (PCR) testing of nasopharyngeal swabs that can identify more than one organism at once."}
{"id": "article-18645_53", "title": "Acute Bronchitis -- Pearls and Other Issues", "content": "Acute bronchitis is usually a self-limiting\u00a0condition and rarely requires treatment. Acute bronchitis\u00a0caused by specific types of pathogens can be treated with antiviral therapies in addition to symptomatic and supportive therapies.", "contents": "Acute Bronchitis -- Pearls and Other Issues. Acute bronchitis is usually a self-limiting\u00a0condition and rarely requires treatment. Acute bronchitis\u00a0caused by specific types of pathogens can be treated with antiviral therapies in addition to symptomatic and supportive therapies."}
{"id": "article-18645_54", "title": "Acute Bronchitis -- Pearls and Other Issues", "content": "Ensuring pulmonary emboli are on the list of differentials for patients with cough and shortness of breath is prudent. Aggressive coughing can\u00a0result in spontaneous pneumothorax or spontaneous pneumomediastinum, underscoring the importance of a CXR when acute\u00a0symptom deterioration occurs.", "contents": "Acute Bronchitis -- Pearls and Other Issues. Ensuring pulmonary emboli are on the list of differentials for patients with cough and shortness of breath is prudent. Aggressive coughing can\u00a0result in spontaneous pneumothorax or spontaneous pneumomediastinum, underscoring the importance of a CXR when acute\u00a0symptom deterioration occurs."}
{"id": "article-18645_55", "title": "Acute Bronchitis -- Enhancing Healthcare Team Outcomes", "content": "In managing acute bronchitis, an interprofessional healthcare team comprising physicians, advanced practitioners, nurses, pharmacists, and other health professionals is critical in delivering patient-centered care, improving outcomes, ensuring patient safety, and optimizing team performance. To achieve these goals, the team must employ various skills and strategies, uphold ethical standards, embrace shared responsibilities, foster open interprofessional communication, and coordinate care effectively. Here are key components for enhancing healthcare team outcomes in acute bronchitis management:", "contents": "Acute Bronchitis -- Enhancing Healthcare Team Outcomes. In managing acute bronchitis, an interprofessional healthcare team comprising physicians, advanced practitioners, nurses, pharmacists, and other health professionals is critical in delivering patient-centered care, improving outcomes, ensuring patient safety, and optimizing team performance. To achieve these goals, the team must employ various skills and strategies, uphold ethical standards, embrace shared responsibilities, foster open interprofessional communication, and coordinate care effectively. Here are key components for enhancing healthcare team outcomes in acute bronchitis management:"}
{"id": "article-18645_56", "title": "Acute Bronchitis -- Enhancing Healthcare Team Outcomes", "content": "Skills and Expertise : Each team member should possess the clinical skills and expertise relevant to their role in acute bronchitis care. Physicians should be proficient in diagnosis and treatment options, nurses should excel in patient monitoring and education, and pharmacists should be well-versed in medication management and potential drug interactions.", "contents": "Acute Bronchitis -- Enhancing Healthcare Team Outcomes. Skills and Expertise : Each team member should possess the clinical skills and expertise relevant to their role in acute bronchitis care. Physicians should be proficient in diagnosis and treatment options, nurses should excel in patient monitoring and education, and pharmacists should be well-versed in medication management and potential drug interactions."}
{"id": "article-18645_57", "title": "Acute Bronchitis -- Enhancing Healthcare Team Outcomes", "content": "Evidence-Based Practice : The team should consistently apply evidence-based guidelines and current best practices in diagnosing and managing acute bronchitis. Staying\u00a0current with the latest research and recommendations is crucial for delivering high-quality care.", "contents": "Acute Bronchitis -- Enhancing Healthcare Team Outcomes. Evidence-Based Practice : The team should consistently apply evidence-based guidelines and current best practices in diagnosing and managing acute bronchitis. Staying\u00a0current with the latest research and recommendations is crucial for delivering high-quality care."}
{"id": "article-18645_58", "title": "Acute Bronchitis -- Enhancing Healthcare Team Outcomes", "content": "Responsibilities and Roles : Clearly defined roles and responsibilities within the team are essential. Physicians diagnose and prescribe treatment, nurses provide patient education and monitor progress, pharmacists ensure safe medication use, and other professionals contribute their specialized knowledge.", "contents": "Acute Bronchitis -- Enhancing Healthcare Team Outcomes. Responsibilities and Roles : Clearly defined roles and responsibilities within the team are essential. Physicians diagnose and prescribe treatment, nurses provide patient education and monitor progress, pharmacists ensure safe medication use, and other professionals contribute their specialized knowledge."}
{"id": "article-18645_59", "title": "Acute Bronchitis -- Enhancing Healthcare Team Outcomes", "content": "Care Coordination : Coordinating care is central to optimizing patient outcomes. This involves scheduling follow-up appointments, ensuring adherence to treatment plans, and actively involving patients in their care decisions.", "contents": "Acute Bronchitis -- Enhancing Healthcare Team Outcomes. Care Coordination : Coordinating care is central to optimizing patient outcomes. This involves scheduling follow-up appointments, ensuring adherence to treatment plans, and actively involving patients in their care decisions."}
{"id": "article-18645_60", "title": "Acute Bronchitis -- Enhancing Healthcare Team Outcomes", "content": "Patient Education : Nurses are vital in educating patients about their condition, treatment options, and preventive measures. Empowering patients with knowledge encourages active participation in their care and contributes to improved outcomes.", "contents": "Acute Bronchitis -- Enhancing Healthcare Team Outcomes. Patient Education : Nurses are vital in educating patients about their condition, treatment options, and preventive measures. Empowering patients with knowledge encourages active participation in their care and contributes to improved outcomes."}
{"id": "article-18645_61", "title": "Acute Bronchitis -- Enhancing Healthcare Team Outcomes", "content": "Medication Management : Pharmacists should review medication regimens to identify potential interactions and allergies, which can help minimize adverse drug events and improve patient safety.", "contents": "Acute Bronchitis -- Enhancing Healthcare Team Outcomes. Medication Management : Pharmacists should review medication regimens to identify potential interactions and allergies, which can help minimize adverse drug events and improve patient safety."}
{"id": "article-18645_62", "title": "Acute Bronchitis -- Enhancing Healthcare Team Outcomes", "content": "Timely Follow-Up : Patients with persistent symptoms should have timely follow-up appointments scheduled to assess progress and consider alternative treatments if necessary. This underscores the importance of continuity of care. Acute bronchitis can lead to high morbidity in patients with underlying COPD and other\u00a0preexisting pulmonary conditions.\u00a0It is crucial to recognize that when\u00a0symptoms persist for more than\u00a06 weeks, a reevaluation is essential to\u00a0confirm the accuracy of the initial\u00a0diagnosis and assess the potential presence of complicating factors. [43] [44]", "contents": "Acute Bronchitis -- Enhancing Healthcare Team Outcomes. Timely Follow-Up : Patients with persistent symptoms should have timely follow-up appointments scheduled to assess progress and consider alternative treatments if necessary. This underscores the importance of continuity of care. Acute bronchitis can lead to high morbidity in patients with underlying COPD and other\u00a0preexisting pulmonary conditions.\u00a0It is crucial to recognize that when\u00a0symptoms persist for more than\u00a06 weeks, a reevaluation is essential to\u00a0confirm the accuracy of the initial\u00a0diagnosis and assess the potential presence of complicating factors. [43] [44]"}
{"id": "article-18645_63", "title": "Acute Bronchitis -- Review Questions", "content": "Access free multiple choice questions on this topic. Comment on this article.", "contents": "Acute Bronchitis -- Review Questions. Access free multiple choice questions on this topic. Comment on this article."}